San Francisco Bay Area - Valley California - Cambridge Massachusetts - Palo Alto California | U.S.A.
| Investor Type | Firm |
| Industries | BioTech • HealthTech (& Fitness) • Medical Devices (& Hospital Services) • Healthcare (& Wellness) • Pharmaceutical (& Medicine) |
| Stages | Seed, Series A, Series B |
| Investing | United States |
| Investment Range | $100,000 - $5,000,000 |
| Investment Sweet Spot | $1,500,000 |
| Assets Under Management | $50,000,000 |
About The Fund
Action Potential Venture Capital (APVC) is a corporate venture capital arm of the GlaxoSmithKline group of companies, with a focus on pioneering the future of bioelectronic medicines. Based in Cambridge, Massachusetts, APVC was founded by GSK in 2013, and it takes a hands-on approach to venture capital, investing globally while actively participating in the boards of startups. The fund specializes in bioelectronic medicines, neuromodulation therapies, and the broader healthcare sector, targeting disruptive innovations in the field. Bioelectronic medicine is an emerging field that applies hardware, computing, and material science to control neural or cellular activity, which can treat chronic diseases by harnessing the body's natural electrical systems. APVC aims to modulate the nervous system to address various diseases through targeted forms of energy, including electrical, electromagnetic, and acoustic. The firm invests in companies at Seed, Series A, and Series B stages, with investments ranging from $100,000 to $5,000,000 and a sweet spot of around $1,500,000 per investment. They manage assets totaling $50,000,000. Their commitment goes beyond financial investment to include fostering diversity and an inclusive work environment. They extend this commitment to their investment team and the startups they back, ensuring the formation of a more equitable healthcare investor and entrepreneurial community. APVC's portfolio includes innovative companies that align with their strategic interest in the dynamic and transformative space of bioelectronic medicines. The firm's mission is to bring bioelectronic medicines to patients, playing a pivotal role in the advancement of this novel therapeutic approach.
Action Potential Venture Capital's investments on record
Contact over 100,000 investors!
Built by serial entrepreneurs and ex-VCs, Angels Partners helps entrepreneurs connect with relevant investors in their industry.
With over 100K+ listed investors, our mission is to help founders secure meetings & accelerate their fundraising.
View previous deals, filter by deal size, industry, location and more. It's the fastest way to build a target investor list.
e
We also built a community of hundreds of investors actively prospecting & investing directly on Angels Partners.
Register to become visible to a large community of investors on our platform.
- Prime Founders
- 85 Great Portland St.
- London, U.K.
- contact@angelspartners.com
